Options for the Control of Influenza V, 1st Edition
Proceedings of the International Conference on Options for the Control of Influenza V held in Okinawa, Japan, between 7 and 11, October, 2003, ICS 1263
As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscores not only the significance of influenza,but highlights options for the control of influenza.
As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscores not only the significance of influenza,but highlights options for the control of influenza.
Author Information
Edited by Yoshihiro Kawaoka, Professor, Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokoyo, Tokoyo, Japan
